Eli Lilly and Co has been granted a patent for medication delivery devices with dose delivery sensing capabilities. The devices include a sensed element with surface features and a rotational sensor that generates a signal based on the movement of the sensed element. A controller determines the number of surface features passed by the rotational sensor during dose delivery. The patent also includes an electronic system for a drug delivery device that has a dose setting and drive mechanism, an electronic control unit, and an electrical use detection unit. The system is switched from a first state to a second state based on a use signal generated by the electrical use detection unit. GlobalData’s report on Eli Lilly and Co gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Eli Lilly and Co, Cancer treatment biomarkers was a key innovation area identified from patents. Eli Lilly and Co's grant share as of September 2023 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Patent granted for medication delivery device with dose sensing
A recently granted patent (Publication Number: US11771837B2) describes an electronic system for a drug delivery device. The system includes a dose setting and drive mechanism that allows users to set and deliver a specific dose of medication. The mechanism consists of two members, with the first member rotating relative to the second member during the dose delivery operation.
The electronic system also includes an electronic control unit that manages the operation of the device. It has two states: a first state and a second state. The second state consumes more electrical power compared to the first state. To detect when the user starts the dose delivery operation, an electrical use detection unit is connected to the electronic control unit. This unit generates a use signal indicating that the user has initiated the delivery process.
The first member of the dose setting and drive mechanism is equipped with teeth arranged around its circumference. The electronic system incorporates a switch that interacts with these teeth during the rotation of the first member. The switch consists of a pair of contacts that make contact with each other when engaged by one of the teeth, generating the use signal. In response to this signal, the electronic control unit switches the system from the first state to the second state.
Additional details provided in the patent include the pivotal mounting of the switch, allowing it to move pivotally when engaged by a tooth. The first member of the mechanism can also move relative to the housing of the electronic system or the drug delivery device during the dose delivery operation. Furthermore, the patent mentions that the first member is referred to as the dose dial member, while the second member is called the actuator.
The patent also mentions the application of this electronic system in a drug delivery device. The device includes the described electronic system and a reservoir containing the drug to be delivered.
Overall, this granted patent outlines an electronic system for a drug delivery device that incorporates a dose setting and drive mechanism, an electronic control unit, and an electrical use detection unit. The system allows users to set and deliver specific doses of medication, with the electronic control unit managing the device's operation based on the use signal generated by the electrical use detection unit.
To know more about GlobalData’s detailed insights on Eli Lilly and Co, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
